RTFCCR/LUNGevity Award for Overcoming Treatment Resistance
Provides four, clinical trial investigators addressing lung-cancer treatment resistance through the RTFCCR/LUNGevity Award for Overcoming Treatment Resistance.
The RTFCCR/LUNGevity Award for Overcoming Treatment Resistance is a joint grant program co-funded by the Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and LUNGevity Foundation, a nonprofit dedicated to improving outcomes for people living with lung cancer. The award targets a critical unmet need: the high rate at which lung cancer patients develop resistance to therapies or experien…
Up to four-year clinical trial grants addressing lung cancer treatment resistance, including therapies to prevent or overcome resistance, lab-developed monitoring tests, and technologies for earlier recurrence detection.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline